亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial

医学 射血分数 心力衰竭 心脏病学 内科学 分数(化学) 有机化学 化学
作者
Javed Butler,Francesco Fioretti,Ciaran J. McMullan,Kevin J. Anstrom,Irina Barash,Marc P. Bonaca,Maria Borentain,Stefano Corda,Pedro Teixeira,Justin A. Ezekowitz,Davis Gates,Carolyn S.P. Lam,Eldrin F. Lewis,JoAnn Lindenfeld,Robert J. Mentz,Christopher M. O’Connor,Piotr Ponikowski,Yogesh N V Reddy,Giuseppe Rosano,Clara Saldarriaga
出处
期刊:European Heart Journal [Oxford University Press]
被引量:1
标识
DOI:10.1093/eurheartj/ehaf655
摘要

In the VICTOR trial (NCT05093933), vericiguat was neutral for the primary composite endpoint of cardiovascular death or hospitalization for heart failure (HF). VICTOR was powered to independently assess cardiovascular death. This study reports detailed analysis on the effects of vericiguat on mortality. VICTOR, a double-blind, placebo-controlled, randomized trial, enrolled 6105 ambulatory patients with HF and reduced ejection fraction (HFrEF) without recent worsening and randomized them to vericiguat or placebo. The main outcome for this analysis was the prespecified secondary endpoint of cardiovascular death. All-cause death, sudden cardiac death, and death related to HF were also assessed. Over a median of 19.7 months (interquartile range 14.6-25.4), cardiovascular deaths occurred in 292 patients (5.7 deaths per 100 patient-years) and 346 patients (6.8 deaths per 100 patient-years) in the vericiguat and placebo groups, respectively (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.71-0.97; P = 0.020). Risk of death from any cause was lower with vericiguat vs placebo (377 [7.3 deaths per 100 patient-years] vs 440 [8.6 deaths per 100 patient-years]; HR 0.84, 95% CI 0.74-0.97; P = 0.015). Sudden cardiac death and HF-related deaths were lower with vericiguat vs placebo (1.6 vs 2.2 events per 100 patient-years; HR 0.75, 95% CI 0.56-0.99; P = 0.042 and 1.7 vs 2.4 events per 100 patient-years; HR 0.71, 95% CI 0.54-0.94; P = 0.016, respectively). Lower mortality rates were consistent across subgroups including baseline therapy. Consistent cardiovascular and all-cause mortality benefit was seen across baseline N-terminal pro-B-type natriuretic peptide levels. In ambulatory well-treated participants with HFrEF, vericiguat was associated with clinically meaningful reductions in the key secondary outcome of cardiovascular death, as well as all-cause mortality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温馨家园完成签到 ,获得积分10
15秒前
西山菩提完成签到,获得积分10
1分钟前
1分钟前
2分钟前
liliAnh完成签到 ,获得积分10
4分钟前
5分钟前
一盏壶完成签到,获得积分10
7分钟前
布吉岛呀完成签到 ,获得积分10
8分钟前
8分钟前
蛋白积聚完成签到,获得积分10
9分钟前
9分钟前
hyxiaoren发布了新的文献求助30
9分钟前
陈俐俐完成签到,获得积分10
9分钟前
科研通AI5应助hyxiaoren采纳,获得30
9分钟前
9分钟前
TJW发布了新的文献求助30
9分钟前
hayden完成签到 ,获得积分10
9分钟前
TJW完成签到,获得积分20
9分钟前
10分钟前
未寄出的信笺积满灰尘完成签到,获得积分10
10分钟前
满怀信心完成签到 ,获得积分10
10分钟前
柯伊达完成签到 ,获得积分10
10分钟前
hesurina发布了新的文献求助100
10分钟前
喻初原完成签到 ,获得积分10
11分钟前
hyxiaoren完成签到,获得积分20
11分钟前
poki完成签到 ,获得积分10
11分钟前
lorentzh完成签到,获得积分10
11分钟前
小蘑菇应助Demi_Ming采纳,获得10
11分钟前
Nancy0818完成签到 ,获得积分10
11分钟前
深情安青应助Demi_Ming采纳,获得10
12分钟前
12分钟前
Demi_Ming发布了新的文献求助10
12分钟前
12分钟前
Demi_Ming发布了新的文献求助10
12分钟前
Magali发布了新的文献求助10
13分钟前
一點點发布了新的文献求助10
13分钟前
伊笙完成签到 ,获得积分0
13分钟前
fsznc完成签到 ,获得积分0
14分钟前
LiLi完成签到 ,获得积分10
14分钟前
man完成签到 ,获得积分10
15分钟前
高分求助中
Rapid Review of Electrodiagnostic and Neuromuscular Medicine: A Must-Have Reference for Neurologists and Physiatrists 1000
Bond and Bond Option Pricing based on the Current Term Structure 500
求中国石油大学(北京)图书馆的硕士论文,作者董晨,十年前搞太赫兹的 500
Narrative Method and Narrative form in Masaccio's Tribute Money 500
基于3um sOl硅光平台的集成发射芯片关键器件研究 500
Educational Research: Planning, Conducting, and Evaluating Quantitative and Qualitative Research 460
Development in Infancy 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4787313
求助须知:如何正确求助?哪些是违规求助? 4112924
关于积分的说明 12723613
捐赠科研通 3838578
什么是DOI,文献DOI怎么找? 2116259
邀请新用户注册赠送积分活动 1139072
关于科研通互助平台的介绍 1026026